1 Stock With Growth Potential

From Wealthy Millionaire | Ad

This could be one of the best stocks to consider during this bear market run.

Click for ticker & full details

BEAM Insider Trading (Beam Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $15,840,530.13

Beam Therapeutics Insider Trading History Chart

Beam Therapeutics Share Price & Price History

^$38.85

▼ -1.57 (-3.88%)

As of 06/30/2022 02:20 PM ET

Days: 30 | 90 | 365

47-second trade demo: how to make ANY bear market cough up cash

From Tradesmith | Ad

It's a bloodbath out there. But while most investors sweat bullets wondering what to do… (And where to find ANY safe haven for their money). Trading expert Keith Kaplan has created an "income loop" algorithm …that actually FORCES instant cash out of every trade. Click here to view a live "demo".

>>>

Beam Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/28/2022	John M Evans	CEO	Sell	30,000	$37.98	$1,139,400.00	1,118,520
4/13/2022	Fmr Llc	Insider	Sell	19,466	$50.41	$981,281.06
3/31/2022	Giuseppe Ciaramella	Insider	Sell	1,859	$59.11	$109,885.49	115,614
3/31/2022	John M Evans	CEO	Sell	6,261	$59.11	$370,087.71	1,089,070
3/31/2022	Terry-Ann Burrell	CFO	Sell	1,787	$59.11	$105,629.57	38,278
12/21/2021	Giuseppe Ciaramella	Insider	Sell	25,104	$85.69	$2,151,161.76
10/6/2021	John M Evans	CEO	Sell	27,700	$83.80	$2,321,260.00
8/19/2021	John M Evans	CEO	Sell	20,000	$99.49	$1,989,800.00
7/7/2021	John M. Evans	CEO	Sell	25,000	$107.87	$2,696,750.00	1,046,525
7/6/2021	Graham K Cooper	Director	Sell	2,614	$120.61	$315,274.54
6/30/2021	Terry-Ann Burrell	CFO	Sell	30,000	$122.00	$3,660,000.00
6/28/2021	Giuseppe Ciaramella	Insider	Sell	78,580	$107.35	$8,435,563.00	123,341
6/28/2021	Graham K Cooper	Director	Sell	12,045	$106.34	$1,280,865.30	12,045
6/28/2021	Terry-Ann Burrell	CFO	Sell	45,000	$107.69	$4,846,050.00	69,809
4/21/2021	John M Evans	CEO	Sell	25,000	$70.49	$1,762,250.00	1,038,966

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Beam Therapeutics (NASDAQ:BEAM)

68.80% of Beam Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Beam Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/24/2022	Temasek Holdings Private Ltd	3,959,212	$226.86M	0.9%	+14.5%	5.634%
6/7/2022	Bank of America Corp DE	137,713	$7.89M	0.0%	+26.0%	0.196%
6/2/2022	Verition Fund Management LLC	12,824	$0.74M	0.0%	+101.9%	0.018%
5/23/2022	Neuberger Berman Group LLC	22,629	$1.30M	0.0%	-14.7%	0.032%
5/20/2022	The Manufacturers Life Insurance Company	21,234	$1.22M	0.0%	-17.5%	0.030%
5/18/2022	Golden State Equity Partners	9,690	$0.56M	0.2%	+46.8%	0.014%
5/17/2022	Virtu Financial LLC	7,909	$0.45M	0.0%	N/A	0.011%
5/17/2022	Point72 Hong Kong Ltd	5,763	$0.33M	0.0%	N/A	0.008%
5/17/2022	Quantbot Technologies LP	12,261	$0.70M	0.1%	+1,708.4%	0.017%
5/17/2022	Royal Bank of Canada	19,786	$1.13M	0.0%	+222.5%	0.028%
5/17/2022	Dynamic Technology Lab Private Ltd	17,370	$1M	0.1%	N/A	0.025%
5/17/2022	Farallon Capital Management LLC	2,594,387	$148.66M	0.8%	+14.5%	3.692%
5/17/2022	Gilder Gagnon Howe & Co. LLC	157,609	$9.03M	0.1%	+0.9%	0.224%
5/17/2022	Guggenheim Capital LLC	91,336	$5.23M	0.0%	+2.4%	0.130%
5/16/2022	California State Teachers Retirement System	51,068	$2.93M	0.0%	-8.7%	0.073%
5/16/2022	Goldman Sachs Group Inc.	829,247	$47.52M	0.0%	-14.9%	1.180%
5/16/2022	Captrust Financial Advisors	1,845	$0.11M	0.0%	+29.9%	0.003%
5/16/2022	Deep Track Capital LP	763,750	$43.76M	2.8%	+9.1%	1.087%
5/16/2022	State Street Corp	1,981,546	$113.54M	0.0%	+17.7%	2.820%
5/16/2022	Engineers Gate Manager LP	4,824	$0.28M	0.0%	N/A	0.007%
5/16/2022	Vident Investment Advisory LLC	4,825	$0.28M	0.0%	-6.5%	0.007%
5/16/2022	UBS Group AG	65,758	$3.77M	0.0%	+70.4%	0.094%
5/16/2022	Granahan Investment Management LLC	108,227	$6.20M	0.2%	+29.8%	0.154%
5/13/2022	Evolutionary Tree Capital Management LLC	34,296	$1.97M	1.4%	-28.7%	0.049%
5/13/2022	Bellevue Group AG	582,821	$33.40M	0.4%	-4.9%	0.829%
5/13/2022	Northern Trust Corp	461,043	$26.42M	0.0%	-3.9%	0.656%
5/13/2022	Verition Fund Management LLC	12,824	$0.74M	0.0%	+101.9%	0.018%
5/13/2022	Charles Schwab Investment Management Inc.	370,916	$21.25M	0.0%	+6.6%	0.528%
5/13/2022	Lazard Asset Management LLC	70,850	$4.06M	0.0%	+33.4%	0.101%
5/13/2022	Arrowstreet Capital Limited Partnership	19,129	$1.10M	0.0%	N/A	0.027%
5/13/2022	Penserra Capital Management LLC	1,700	$97K	0.0%	N/A	0.002%
5/13/2022	First Trust Advisors LP	7,955	$0.46M	0.0%	-9.9%	0.011%
5/13/2022	American International Group Inc.	25,414	$1.46M	0.0%	-6.6%	0.036%
5/13/2022	Pearl River Capital LLC	3,610	$0.21M	0.1%	N/A	0.005%
5/13/2022	Brown Brothers Harriman & Co.	1,189	$68K	0.0%	-82.7%	0.002%
5/13/2022	Vanguard Group Inc.	4,712,010	$270M	0.0%	+0.3%	6.706%
5/13/2022	Canada Pension Plan Investment Board	1,499	$86K	0.0%	N/A	0.002%
5/13/2022	Blair William & Co. IL	6,292	$0.36M	0.0%	+40.1%	0.009%
5/13/2022	Dimensional Fund Advisors LP	18,572	$1.06M	0.0%	+74.2%	0.026%
5/12/2022	BlackRock Inc.	4,038,191	$231.39M	0.0%	-0.6%	5.755%
5/12/2022	Rhumbline Advisers	54,202	$3.11M	0.0%	+4.6%	0.077%
5/12/2022	Jacob Asset Management of New York LLC	2,994	$0.17M	0.1%	N/A	0.004%
5/12/2022	Metropolitan Life Insurance Co NY	3,264	$0.19M	0.0%	-75.1%	0.005%
5/12/2022	MetLife Investment Management LLC	27,129	$1.55M	0.0%	+56.8%	0.039%
5/12/2022	Renaissance Capital LLC	15,955	$0.91M	0.4%	-23.0%	0.023%
5/12/2022	D.A. Davidson & CO.	11,631	$0.67M	0.0%	+12.9%	0.017%
5/12/2022	Capital Fund Management S.A.	25,225	$1.45M	0.0%	N/A	0.036%
5/12/2022	E Fund Management Co. Ltd.	4,404	$0.25M	0.0%	N/A	0.006%
5/12/2022	CQS US LLC	96,038	$5.50M	0.4%	N/A	0.137%
5/12/2022	Citigroup Inc.	50,725	$2.91M	0.0%	-41.9%	0.072%
5/12/2022	HighTower Advisors LLC	4,352	$0.25M	0.0%	+15.3%	0.006%
5/11/2022	Reynders McVeigh Capital Management LLC	83,264	$4.77M	0.3%	+5.2%	0.119%
5/11/2022	US Bancorp DE	10,802	$0.62M	0.0%	+5.6%	0.015%
5/11/2022	Bank of New York Mellon Corp	247,376	$14.18M	0.0%	-0.9%	0.353%
5/11/2022	Raymond James & Associates	4,163	$0.24M	0.0%	+43.6%	0.006%
5/11/2022	JPMorgan Chase & Co.	742,669	$42.56M	0.0%	+1.3%	1.058%
5/10/2022	Profund Advisors LLC	7,117	$0.41M	0.0%	-10.1%	0.010%
5/10/2022	ProShare Advisors LLC	17,747	$1.02M	0.0%	-19.0%	0.025%
5/10/2022	Moody Aldrich Partners LLC	25,995	$1.49M	0.2%	+7.9%	0.037%
5/10/2022	Steel Peak Wealth Management LLC	7,697	$0.44M	0.0%	N/A	0.011%
5/10/2022	Parametrica Management Ltd	7,371	$0.42M	0.3%	N/A	0.011%
5/10/2022	B. Metzler seel. Sohn & Co. AG	8,390	$0.48M	0.0%	N/A	0.012%
5/10/2022	Avidian Wealth Solutions LLC	3,741	$0.21M	0.0%	N/A	0.005%
5/9/2022	Principal Financial Group Inc.	21,368	$1.23M	0.0%	+1.7%	0.030%
5/9/2022	Swiss National Bank	80,600	$4.62M	0.0%	+10.3%	0.115%
5/9/2022	Bank Julius Baer & Co. Ltd Zurich	2,653	$0.15M	0.0%	N/A	0.004%
5/9/2022	Teacher Retirement System of Texas	7,027	$0.40M	0.0%	+10.8%	0.010%
5/9/2022	Qube Research & Technologies Ltd	18,773	$1.08M	0.0%	N/A	0.027%
5/6/2022	Los Angeles Capital Management LLC	12,297	$0.71M	0.0%	+51.9%	0.018%
5/6/2022	WCM Investment Management LLC	78,157	$4.48M	0.0%	+10.7%	0.111%
5/6/2022	Nikko Asset Management Americas Inc.	283,509	$16.30M	0.1%	+25.9%	0.404%
5/5/2022	Capital Advisors Inc. OK	96,286	$5.52M	0.2%	+5.7%	0.137%
5/5/2022	New York State Common Retirement Fund	43,689	$2.50M	0.0%	+9.1%	0.062%
5/5/2022	Russell Investments Group Ltd.	90,220	$5.17M	0.0%	+1.0%	0.129%
5/4/2022	Victory Capital Management Inc.	685,186	$38.78M	0.0%	+18.6%	0.976%
5/4/2022	Commonwealth Equity Services LLC	8,198	$0.47M	0.0%	+14.5%	0.012%
5/4/2022	Envestnet Asset Management Inc.	3,552	$0.20M	0.0%	N/A	0.005%
5/4/2022	Arizona State Retirement System	9,209	$0.53M	0.0%	+3.1%	0.013%
5/3/2022	State of New Jersey Common Pension Fund D	38,796	$2.22M	0.0%	+23.9%	0.055%
5/2/2022	Phoenix Wealth Advisors	7,970	$0.44M	0.5%	N/A	0.011%
4/29/2022	SG Americas Securities LLC	5,617	$0.32M	0.0%	-61.5%	0.008%
4/27/2022	Compagnie Lombard Odier SCmA	1,080	$62K	0.0%	N/A	0.002%
4/27/2022	Sumitomo Mitsui Trust Holdings Inc.	283,509	$16.25M	0.0%	+25.9%	0.412%
4/21/2022	Strs Ohio	1,000	$57K	0.0%	-67.7%	0.001%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	9,596	$0.55M	0.0%	+4.1%	0.014%
4/21/2022	K.J. Harrison & Partners Inc	16,497	$0.95M	0.2%	+43.5%	0.024%
4/20/2022	Kessler Investment Group LLC	1,005	$58K	0.0%	N/A	0.001%
4/20/2022	Polianta Ltd	16,100	$0.92M	0.6%	+5.2%	0.023%
4/19/2022	ARK Investment Management LLC	8,200,749	$469.90M	2.0%	+2.7%	11.932%
4/14/2022	Cutler Group LP	925	$53K	0.0%	+825.0%	0.001%
2/19/2022	Wexford Capital LP	11,626	$0.93M	0.0%	N/A	0.017%
2/16/2022	Kraematon Investment Advisors Inc.	5,415	$0.43M	0.4%	N/A	0.008%
2/15/2022	Marshall Wace LLP	124,993	$9.96M	0.0%	N/A	0.183%
2/15/2022	Capital Impact Advisors LLC	7,472	$0.60M	0.4%	N/A	0.011%
2/14/2022	Itau Unibanco Holding S.A.	1,110	$91K	0.0%	N/A	0.002%
2/14/2022	Redmile Group LLC	1,885,850	$150.28M	3.4%	-4.5%	2.768%
2/14/2022	Family Management Corp	9,120	$0.73M	0.2%	+64.8%	0.013%
2/14/2022	Point72 Asset Management L.P.	44,900	$3.58M	0.0%	N/A	0.066%
2/14/2022	Guggenheim Capital LLC	89,154	$7.10M	0.0%	+23.3%	0.131%
2/14/2022	State Street Corp	1,683,163	$134.13M	0.0%	+20.1%	2.470%

Data available starting January 2016

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children's Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Today's Range

Now: $38.85

$38.18

$40.17

50 Day Range

MA: $36.59

$29.86

$44.23

52 Week Range

Now: $38.85

$27.77

$138.52

Volume

15,953 shs

Average Volume

1,193,985 shs

Market Capitalization

$2.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.61

Who are the company insiders with the largest holdings of Beam Therapeutics?: Beam Therapeutics' top insider investors include:
John M Evans (CEO)
John M Evans (CEO)
Giuseppe Ciaramella (Insider)
Terry-Ann Burrell (CFO)
Graham K Cooper (Director)
Fmr Llc (Insider)
Learn More about top insider investors at Beam Therapeutics.